Article info

Download PDFPDF
CP-151 Efficacy of 4, 12 and 24 weeks of treatment with ledipasvir/sofosbuvir, simeprevir, sofosbuvir, sofosbuvir/simeprevir and sofosbuvir/daclatasvir in patients with chronic hepatitis C virus

Authors

Citation

Ruiz AS, Iglesias MB, Diaz TM, et al
CP-151 Efficacy of 4, 12 and 24 weeks of treatment with ledipasvir/sofosbuvir, simeprevir, sofosbuvir, sofosbuvir/simeprevir and sofosbuvir/daclatasvir in patients with chronic hepatitis C virus

Publication history

  • First published February 14, 2016.
Online issue publication 
February 14, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.